Intelligence · Clinical Development
Pipeline search results
Programs matching “aspirin” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 32 pipeline programs matching "aspirin" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
AERD-COV19
COLLEGIUM PHARMACEUTICAL, INC
aspirin-exacerbated respiratory disease
1 trial -
Aspirin
United Therapeutics Europe Ltd
Node Positive HER2 Negative Breast Cancer
1 trial -
Aspirin 75 mg daily
Century Therapeutics
Intracerebral Haemorrhage
1 trial -
CAMER5UA
United Therapeutics Europe Ltd
Cervical Artery Dissection
1 trial -
Lansoprazole and naproxen and aspirin
Takeda
Osteoarthritis
1 trial -
PL2200 Aspirin Capsules
Protalix BioTherapeutics
Diabetes Mellitus, Type 2
2 trials -
Ticagrelor and Aspirin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Stroke
1 trial -
clopidogrel and aspirin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Atherosclerosis
1 trial -
Aspirin
United Therapeutics Europe Ltd
Vestibular Schwannoma
1 trial -
Aspirin
Cardiff Oncology
Venous Leg Ulcer
1 trial -
Aspirin 75mg
United Therapeutics Europe Ltd
Acute Lung Injury
1 trial -
Aspirin Challenge
Regeneron UK Limited
Aspirin-exacerbated Respiratory Disease
1 trial -
Ifetroban Oral Capsule
CUMBERLAND PHARMACEUTICALS INC
Asthma, Aspirin-Induced
1 trial -
Ifetroban, Oral Capsule
CUMBERLAND PHARMACEUTICALS INC
Aspirin Exacerbated Respiratory Disease (AERD)
1 trial -
aspirin and atorvastatin
United Therapeutics Europe Ltd
Cardiovascular Risk Factor
1 trial -
Aspirin
Regeneron UK Limited
Healthy Volunteers
1 trial -
Aspirin
Protalix BioTherapeutics
Bioequivalence
1 trial -
Pharmaceutical-lipid aspirin (PL-ASA)
Protalix BioTherapeutics
Bioequivalence
1 trial -
Aspirin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Coronary Syndrome
1 trial -
Aspirin
The First People's Hospital of Lianyungang
G6PD Deficiency
1 trial -
Aspirin
The First People's Hospital of Lianyungang
Recurrent Pregnancy Loss
1 trial -
Aspirin + Clopidogrel + Rivaroxaban
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Coronary Artery Disease
1 trial -
aspirin 100mg/d therapy
The First People's Hospital of Lianyungang
Coronary Atherosclerosis
1 trial -
aspirin and clopidogrel
The First People's Hospital of Lianyungang
Atrial Fibrillation
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.